Peer Review History
| Original SubmissionMay 17, 2024 |
|---|
|
PONE-D-24-19931Phenylacetic acid induces NIN expression in hydroponically treated roots of the actinorhizal plant Datisca glomerataPLOS ONE Dear Dr. Pawlowski, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 25 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Rajappa Janyanaik Joga, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why. 3. Thank you for stating the following financial disclosure: “Swedish Research Council Vetenskapsrådet VR2012-03061 to KP Carl Tryggers Stiftelse för Vetenskaplig Forskning CTS13:354 to KP” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: No Reviewer #3: Yes Reviewer #4: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No Reviewer #3: N/A Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In comparison with legumes, genes invovled in actinorhizal nodule organogenesis remain less understood. In this study, the authors analyzed the responses of several nodulation genes in Datisca glomeratac hydroponic system.This study supports the view that cytokinin signaling is central for cortex-induced nodules of L. japonicus but acts as an antagonist to the induction of pericycle-induced nodules of D. glomerata by PAA The results would be potentially interesting to the field and teh findings are interesting. I have several specific comments: 1. The authors showed candidate gene expression in response to phytohormone treatment . However, no data was presented how the phytohormones affect nodule number or formation. Physiological observation should be performed regarding the nodulation phenotype in different treatments. 2. The picture of the hydroponic culture should be moved from supplemental figure to Fig.1. 3. Phylogenetic trees should be shown for the genes used in this study, demonstrating that these are indeed orthologs of nodulation genes in legumes. 4.The agricultural significance of legume and actinorhizal nodulation should be introduced in the first paragraph. For example, nodulation in legumes reduce fertilizer usage and improves soybean yield (https://doi.org/10.1038/s41477-024-01696-x ). Reviewer #2: In the manuscript Salgado et al., describes the primary hormonal response in primary symbiotic specific transcription factors after treatment with phytohormone. The major take home massage of this paper is that in the actinorhizal plant Datisca glomerata the gene expression of NIN induces after auxin (PAA) treatment instead of CK (BAP) treatment. This is an important massage for the nodule biologist. Despite this fact, there are some important lacunae in the manuscript that need to be addressed. Major points: NIN1 expresses in root and eventually induces in nodule where as NIN2 is nodule specific. Further, In the figure 1 where both NIN1 and NIN2 expression has been shown there it is clear that NIN2 expression is higher than NIN1. If so, then why the complete study is conducted only using NIN1. Only the proximal promoter analysis can not be used as an logic to not conduct the qRT-PCR analysis of NIN2. Minor points. 1. In the page 3 in introduction the involvement of the phytohormone para written in an confusing manor. 2. Page 4, ‘suggesting that DgNIN1 signaling might dependent on auxin or cytokinin’. There should be auxin and/or cytokinin. 3. Page5. Preliminary assays confirmed ARR9 as a suitable marker gene for cytokinin in D. glomerata, owing to an increase of ARR9 mRNA levels in the presence of BAP (discussed below), please add figure number here. 4. In Fig 1, the statistics is not marked as mentioned in the legend. For all the figure please mention the number of technical and biological replicates. 5. The transcriptional profile exhibited by CYCLOPS in this assay indicates that its transcription is tightly regulated by BAP levels within the range of 10 nM to 100 nM. Why the CRE1 cytokinin receptor gene was not taken into study? I suggest to check CRE1 expression as well. 6. The expression of L. japonicus cytokinin oxidase/dehydrogenase3 (LjCkx3; [56]) was induced by BAP when applied for a period of 8h. In the Fig 2, if auxin and BAP are antagonists then why CKX3 expression did not decrease in PAA, NAA treatment? Please elaborate 7. D. glomerata roots exhibits a different temporal window to react to possible effects of cytokinin when compared with roots of L. japonicus, which could be best explained by differences in root development between the two species. Please elaborate few lines about root developmental difference between these two species. 8. PBZ-treated roots showed a significant decrease in mRNA abundance of CYCLOPS and NF-YA1 when compared with their control and AVG-treated counterparts. The significance was not marked in the Fig 5. Discussion 9. Since the induction of the actinorhizal nodule primordium takes place in the root pericycle [42], the same mechanism would not necessarily be expected for actinorhizal plants. Please elaborate this and connect with the provided evidences from this study. 10. Indeed, the results of this study showed unambiguously that the expression of D. glomerata NIN1 is repressed by the synthetic cytokinin BAP and induced by the natural auxin PAA, though not by the synthetic auxin NAA. How the LjNIN and DgNIN1 is receiving this application of exogenous PAA and NAA in different style? Can you add some comments about its signalling? Reviewer #3: Comments The study conducted by Salgado et al, focused on the genes and phytohormones requirements during the nodulation program of the actinorhizal plant Datisca glomerata, a largely unknown process. The purpose of the study is clear and very well written. This working model represents numerous challenges, that limit the approaches employed in model legumes. Nonetheless, they obtained interesting results on the differential responses of D. glomerata roots on symbiotic gene expression, after treatment with synthetic phytohormones, specially cytokinin. Undoubtedly this work provides valuable information to the community interested in plant-microbes mutualistic associations. Minor comments Strictly talking, the title of the manuscript is correct, but probably not very “catchy”. The authors could consider a title that includes the terms hormones and remove Phenylacetic acid. The different phytohormone-related gene expression might be highlighted. Page 1. “ In all these interactions, the microsymbionts are not vertically transmitted”. In common bean and probably other legumes, rhizobia can be vertically transmitted (https://doi.org/10.1111/j.1574-6941.1998.tb00513.x) Results: The length of the subsections can be shortened Figure Legends: Please include the number of harvested plants per biological replicate. Cytokinin and cytokinin-related genes seem to be differentially required in “unusual” nodulation programs, for instance the nodulation in Parasponia (doi: 10.3389/fpls.2018.00284) and the intercellular infection program in Lotus japonicus (https://doi.org/10.1093/plphys/kiaa049). The authors could discuss more about it. Reviewer #4: The present study focuses on hormonal regulation of genes encoding key regulators of symbiotic nodules development in actinorhizal plant Datisca glomerata. Molecular mechanisms underlying the symbiotic nodule development and its hormonal control is well established for legume-rhizobia symbiosis; however, for actinorhizal plants, its regulation remains less understood. This study is aimed to fill this gap. Overall, the results of this study are interesting and propose that key regulators of symbiosis are regulated differently in legumes and actinorhizal plant D. glomerata: notably, the expression of the DgNIN gene is induced by auxin (phenylacetic acid), but not by cytokinin BAP as it was shown for L. japonicus and other model legumes. However, the obtained results require further clarification and discussion. Comments: 1. The inhibitory effect of BAP on expression levels of CYCLOPS, NIN1 and NF-YA1 was shown for 30-day-old plants. However, at this age, in a trial experiment using roots of 30-day-old D. glomerata seedlings, the exogenous application of 50 nM PAA did not lead to any changes in expression of either CYCLOPS or NIN1 in 24h treatments. Therefore, authors suggested the possibility that root development could have a pivotal influence on the transcription of CYCLOPS and NIN1 at this stage (30-day-old D. glomerata seedlings). In 54-day-old seedlings, 10 and 50 nM PAA induced NIN1 expression, however, in this experiment, 10 and 50 nM BAP did not downregulate NIN1 activity at this stage (10 nM BAP even tends (although non-significantly) to increase NIN1 expression, Figure 4). Therefore, the conclusion made by the authors (throughout the Discussion section) that BAP inhibits NIN expression in D. glomerata is not quite correct. These findings should be discussed more accurately. The effect of BAP and auxin treatment on gene expression levels in D. glomerata should be compared at the same developmental stage. 2. Expression of NIN1 is induced in nodules compared to roots, while NIN2 is expressed nodule-specifically. Since NIN1 expression is not nodule-specific, can this gene have functions in root development that are not related to the development of symbiotic nodules, but some other functions, possibly related to the development of lateral root? It would be nice to discuss this issue. Why only NIN1 expression was checked, not NIN2, which is nodule-specific? 3. Previously, it was reported that CYCLOPS binding site and CE-region (containing many putative cytokinin response regulator binding sites) are conserved in legume NIN promoters (Liu et al., 2019; Liu and Bisseling. 2020, doi: 10.3390/genes11070777). CYCLOPS/IPD3 binding site is located about 3 kb upstream of the start codon, whereas CE-region is located far upstream from the NIN start codon (in Medicago it is about 18 kb upstream, and in Lotus it is about 45 kb upstream of the NIN start codon) (Liu et al., 2019, DOI: 10.1105/tpc.18.00478 ). It was suggested that the gain of the CYCLOPS binding site and CE-region was essential step to establish NIN expression during nodule formation. Are the CYCLOPS-binding site and CE-region conserved in NIN1 and NIN2 genes in D. glomerata as well? It should be checked and discussed in the manuscript in order to understand the evolutionary conservatism of NIN regulation in actinorhizal plants. 4. Gauthier-Coles et al., 2019 (DOI: 10.3389/fpls.2018.01901) reported that nodulating legumes are distinguished by a sensitivity to cytokinin in the root cortex leading to pseudonodule development. However, in the study by Gauthier-Coles et al, a nodulating actinorhizal species Alnus glutinosa formed no pseudonodules after application of cytokinin. In contrast, Rodriguez-Barrueco et al., 1973 (DOI: 10.1111/j.1399-3054.1973.tb03107.x) showed that cytokinin (2IP) application induced pseudonodules on A. glutinosa. Therefore, whether exogeneous cytokinin triggers cortical cells in actinorhizal species remains unclear. It would be nice to clarify this and discuss these findings in accordance with the results obtained in the present study. 5. The beginning of Abstract should be re-written in order to make it clearer and more consistent. 6. In conclusion, it is desirable to add a scheme illustrating the hormonal regulation of the expression levels of key nodule regulators in legumes such as L. japonicus and actinorhizal plant D. glomerata in order to summarize the findings of this study. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Senjuti Sinharoy Reviewer #3: Yes: JESUS MONTIEL Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-24-19931R1The auxin phenylacetic acid induces NIN expression in the actinorhizal plant Datisca glomerata, whereas cytokinin acts antagonisticallyPLOS ONE Dear Dr. Pawlowski, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 02 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Rajappa Janyanaik Joga, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #5: All comments have been addressed Reviewer #6: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #5: Yes Reviewer #6: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #5: Yes Reviewer #6: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #5: Yes Reviewer #6: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #5: Yes Reviewer #6: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #5: Manuscript PONE-D-24-19931R1 After carefully reading the revised version, I came to know that the authors have successfully incorporated all the suggested changes and fully addressed the comments/changes proposed by honorable reviewers. I do not have much comments but only few suggestions that can be considered for further improvement. It is really embarrassing to review the manuscript having no line number. I have only few questions 1- How cytokinin and auxin interact in regulating DgNIN1 expression in Datisca glomerata? 2- What is the role of ethylene and gibberellic acid in PAA-induced expression of DgNIN1? 3- How do nodule formation processes in Datisca glomerata differ from those in Lotus japonicus? Conclusion Usually, the conclusion is the key part of any manuscript, the authors has provided the refence, there is no need of reference. Conclusion of the present must be supported by strong statements justifying and summarizing the results and need to add future prospective. References: Some references are too old, I suggest updating. Figures: I would strongly suggest replacing the figures with original ones having high resolution. Reviewer #6: In the present work, the author focuses on the regulation of genes encoding key regulators of symbiotic nodules development in the actinorhizal plant Datisca glomerata by the phytohormones phenylacetic acid (PAA) or Benzylaminopurine (BAP). The mechanisms underlying the symbiotic nodule development and its hormonal control are well established for legume-rhizobia symbiosis at the molecular level; however, for actinorhizal plants, its regulation remains poorly understood. In my opinion, the results of this study are interesting and propose that key regulators of symbiosis are differentially regulated in legumes and actinorhizal, in particular, the expression of the DgNIN gene, which is induced by PAA, but not by BAP as it was shown for the model legumes Lotus japonicus. The manuscript was previously reviewed, and in my opinion, the authors addressed the concerns raised by the reviewers very well; now, the results are presented and discussed adequately. However, minor concerns must be addressed: - I suggest using “possess” instead of “go back to” in the abstract and introduction. - The term "soil recovery" is more appropriate than "soil reclamation" in the introduction. - The foot of Figure 2 is not correctly indicated: A) It refers to the level of transcripts; B) Refers to the PACE Cis-regulatory elements in the promoter of NIN1 and NIN2… - Reference to the figure 2A is missing in the results section. - Figure S1 is the same as figure S4. Correct the references to S4 Fig in the results section. - The S4 Fig footnote does not correspond to S4 Fig. S4 Fig is missing. - The S5 Fig footnote is not necessary. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #5: No Reviewer #6: Yes: Homero Reyes de la Cruz ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
The auxin phenylacetic acid induces NIN expression in the actinorhizal plant Datisca glomerata, whereas cytokinin acts antagonistically PONE-D-24-19931R2 Dear Dr. Pawlowski We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Anwar Hussain Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #5: All comments have been addressed Reviewer #6: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #5: Yes Reviewer #6: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #5: Yes Reviewer #6: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #5: Yes Reviewer #6: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #5: Yes Reviewer #6: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #5: Thank you for sharing the revised version. The authors have successfully incorporated the changes (where suggested) and now I do not have any further concerns and questions, in my opinion, the manuscript can be accepted for warrant publications. Reviewer #6: In the new version of the manuscript, the authors addressed all the comments raised in the previous submission... ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #5: No Reviewer #6: Yes: Homero Reyes de la Cruz ********** |
| Formally Accepted |
|
PONE-D-24-19931R2 PLOS ONE Dear Dr. Pawlowski, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Anwar Hussain Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .